Source: Kapitales ResearchHeadline

• ASX 200 futures point to a strong opening, advancing 72 points or 0.82%, despite a subdued overnight performance across US equity markets.
• Wall Street finished marginally lower as weakness in several large-cap technology companies offset gains across utilities, materials and energy stocks.
• Alphabet exceeded revenue expectations, driven by an 82% surge in Google Cloud, while Tesla’s stronger revenue was offset by weaker earnings and margins.
• Oil climbed to a one-month high as continued US strikes on Iran and threats to regional infrastructure intensified supply concerns.

Global Markets Overview

Global equity markets delivered a mixed performance as investors assessed corporate earnings, rising oil prices and geopolitical risks. The S&P 500 eased 0.14% to 7,499.00, while the Nasdaq Composite declined 0.57% to 25,691.00 as weakness in major technology stocks weighed on sentiment. The Dow Jones was nearly unchanged, slipping 0.01% to 52,219.00. European markets outperformed, with the FTSE 100 climbing 1.24% to 10,717.00, supported by strength across defensive and commodity-linked sectors. Canada’s S&P/TSX Composite gained 0.33% to 35,485.00, while New Zealand’s NZX 50 advanced 0.78% to 13,763.00. Asian markets were weaker overall, with Japan’s Nikkei falling 0.18% to 66,116.00 and India declining 0.92% to 76,755.00. Overall, global market sentiment remained cautious and regionally uneven.Commodities & Crypto

Commodity markets strengthened as geopolitical tensions and supply concerns supported safe-haven assets and energy prices. Gold rose 1.25% to US$4,128.68 per ounce, while silver gained 0.95% to US$59.66 per ounce as investors sought defensive assets. WTI crude oil climbed 2.95% to US$86.83 a barrel, reaching its highest level in a month amid escalating Middle East tensions and fears of supply disruptions. Uranium also advanced 2.08% to US$5,453.43, reflecting continued interest in nuclear fuel markets. In contrast, copper slipped 1.04% to US$6.44 per pound as concerns over weaker global demand weighed on sentiment. Bitcoin edged 0.39% lower to US$66,009, with cryptocurrency markets remaining subdued as investors adopted a cautious stance ahead of key macroeconomic developments and corporate earnings.Bond Yields

Global government bond yields edged higher, reflecting a cautious investor outlook amid persistent inflation concerns, elevated oil prices and expectations that major central banks could keep interest rates higher for longer. Australia's 10-year government bond yield rose to 4.987%, while the US 10-year Treasury yield increased to 4.659%. The US 30-year Treasury yield also edged higher to 5.149%, indicating modest upward pressure across the longer end of the yield curve. Meanwhile, Japan's 10-year government bond yield stood at 2.741%, remaining near multi-year highs as markets continued to assess the Bank of Japan's policy outlook. Overall, the modest rise in bond yields suggested investors remained cautious while awaiting further economic data and central bank guidance.Key Drivers

• SpaceX declined 6.7%, Meta fell 2.5%, Microsoft lost 1.8% and Tesla eased 1.3%, while Nvidia gained 2.3%.
• Brent crude gained 4.2% to US$95.49 per barrel, driven by heightened geopolitical uncertainty surrounding the escalating US-Iran conflict.
• US forces carried out an 11th consecutive night of strikes on Iranian military and logistics targets.
• Trump threatened to target Iranian infrastructure if Tehran disrupts shipping through the Strait of Hormuz.
• Rising fuel costs lifted US Treasury yields amid concerns that inflation could stay elevated for longer.
• S&P 500 second-quarter earnings are projected to increase approximately 24.7% year-on-year, significantly above the five-year average of 16.4%.
• Goldman Sachs estimated that around US$489 billion of artificial-intelligence-related debt has been issued during the year. Microsoft, Amazon and Meta reportedly account for approximately 40% of total AI-related debt issuance.
• Trump is expected to impose a fresh 10% tariff on imports from dozens of countries by Friday.
• Generic drug imports will remain tariff-free for two years before facing 100% tariffs in 2028 and 200% a year later.
• India is likely to bear the greatest impact, accounting for almost half of all generic medicine shipments to the US.
• The US dollar strengthened against the Japanese yen, with USD/JPY reaching 163 for the first time since 1986.

ASX Company News

• Tourism Holdings Limited (ASX: THL) upgraded its expected FY26 underlying net profit after tax from continuing operations to approximately NZ$46 million, above its previous NZ$40–43 million guidance. The improvement reflected favourable year-end interest outcomes, strong late bookings across all markets and New Zealand vehicle sales at the upper end of expectations.
• Macquarie Group Limited (ASX: MQG) reported satisfactory trading conditions for 1Q27, with stronger contributions from Banking and Financial Services, Commodities and Global Markets, and Macquarie Capital. Assets under management reached AU$748.00 billion, BFS deposits rose to AU$223.30 billion and the home loan portfolio increased to AU$191.50 billion. Its APRA Common Equity Tier 1 capital ratio strengthened to 13.8%.
• Santos Limited (ASX: STO) reported Q2 2026 production of 23.1 mmboe, up 3% quarter-on-quarter, while sales revenue increased 6% to US$1.35 billion. Barossa achieved 97% of its planned production capacity, while Pikka produced around 23,000 barrels per day and remains on track to reach an 80,000-barrel-per-day plateau in Q3 2026.
• James Hardie Industries plc (ASX: JHX) expects Q1 FY27 consolidated net sales of US$1.45–1.48 billion and adjusted EBITDA of US$399–407 million, exceeding previous guidance of US$1.32–1.35 billion and US$354–375 million, respectively. The stronger preliminary result was primarily driven by better-than-expected Siding & Trim sales, supported by solid sell-through and underlying product demand.
• CLINUVEL Pharmaceuticals Limited (ASX: CUV) announced a strategic reorganisation that will relocate its corporate headquarters and key functions to the United States from 1 January 2027. The company plans to reduce its global workforce by approximately 10–20% and focus operational resources on its US pharmaceutical pipeline and commercial strategy to improve regulatory engagement, partnerships and access to deeper capital markets.

Key Economic Drivers (What to Watch Today)

• 11:30 am AEST: Australia Unemployment Rate (Est: 4.4%) – Markets will closely watch labour market conditions for fresh clues on the RBA's interest rate outlook.
• ECB Interest Rate Decision (10:15 pm AEST): Markets expect the ECB to keep interest rates unchanged at 2.40%, with investors watching for policy guidance.
• Middle East Geopolitical Developments: Ongoing tensions between the United States and Iran will remain in focus, as any deterioration could influence energy markets and investor risk appetite.
• Corporate Earnings & Tariff Developments: Investors will assess the latest US corporate earnings and trade policy announcements for their potential impact on global equity markets and investor confidence.

Summary 

• ASX 200 futures are up 72 points, signalling a strong start for the local market despite a subdued overnight session on Wall Street.
• Brent crude rose 4.2% to US$95.49 per barrel as the conflict between the United States and Iran intensified.
• The US dollar strengthened against the Japanese yen, with USD/JPY reaching 163 for the first time since 1986.
• Higher fuel prices pushed US Treasury yields upward as investors worried inflation could remain elevated for longer.
• Investors should continue monitoring inflation, interest rate expectations and geopolitical developments, which are expected to remain key market drivers.

Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.  

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au